Clinical Investment Insider is the official podcast and video series from Health Board Advisors , created for clinicians, operators, and clinician-investors who want to move beyond surface-level conversations and into real decision-making power in healthcare innovation.
25 episodes · publishes weekly · latest 2026-08-12 · ~17 min/episode
Rank
#5631
Substance
41.0
/ 100
Breakdown
Scored 2026-07
Updated monthly
Across the index
#5631 of 6203
Substance
Top 91%
outscores 9% of the index
Clinical Investment Insider by Health Board Advisors ranks #5631 on The B2B Podcast Index with a substance score of 41.0 out of 100, scored across 1 recent episode. It scores highest on guest caliber and insight density. The guest is a genuine practitioner - a CPA with 14 years experience and a former Mercedes-Benz tax analyst running a firm - so relevant credentials exist, but she is a small-firm operator rather than someone who has done investing at scale, and the transcript never demonstrates deep expertise.
Averaged across 1 recently scored episode, with cited evidence.
The episode is dominated by generic platitudes about 'stepping back,' 'devil's advocate,' and 'trusted advisors' with almost no concrete, non-obvious claims a smart operator hasn't heard. The one arguably useful nugget - that tax violations hinder future investors - is stated but never developed.
“not taking the time to step back and look at something through a, uh, 30,000 foot view lens”
“tax violations are a really big hindrance to investors”
Nothing here departs from recycled advice: 'founders think they're the smartest in the room,' 'get external input,' 'dot the T's and cross the eyes.' No contrarian or first-principles thinking appears.
“you're actually not the smartest person in the room for every single discussion”
“dot the T's and cross the eyes”
The guest is a genuine practitioner - a CPA with 14 years experience and a former Mercedes-Benz tax analyst running a firm - so relevant credentials exist, but she is a small-firm operator rather than someone who has done investing at scale, and the transcript never demonstrates deep expertise.
“She has 14 years plus CPA experience and former tax analyst at Mercedes Benz, specialized in investment tax strategy and crypto compliance”
“I have my own CPA firm and I help thousands of people per year”
Ironically, despite the guest championing 'hyper specific' questions, the entire conversation is devoid of named companies, real data, dollar figures, timelines, or case studies. Everything stays abstract.
“I'm helping my client pick up the pieces after an investment has gone poorly”
“your six figure problem is not the same as seven figure problem”
The host delivers long, meandering monologues rather than sharp questions, never pushes back or asks for a concrete example, and the exchange functions largely as a membership promo for HBA rather than a probing interview.
“what drew you to our HBA community? What do you think is that stands out from our ecosystem”
“So how can the HBA ecosystem continue to support”
First period on the Index - history builds from here.
1 scored on substance · 21 tracked in total.
Add this badge to your site - it links back here and updates automatically as you rank.
<a href="https://index.fame.so/show/clinical-investment-insider-by-health-board-advisors" target="_blank" rel="noopener">
<img src="https://index.fame.so/badge/clinical-investment-insider-by-health-board-advisors/badge.svg" alt="Ranked #812 on The B2B Podcast Index" width="360" height="136" />
</a>Track Clinical Investment Insider by Health Board Advisors's rank
Get an email whenever this show moves up or down the Index. Monthly at most, no spam.
The themes that come up most across this show's episodes.
TechSurge: Deep Tech Podcast
Celesta Capital | Deep Tech Venture Capital Firm
A Product Market Fit Show
Mistral.vc
The Puck: Venture Capital and Beyond
Jim Baer
Venture Unlocked
Samir Kaji
Engineering Founders
The Engineering Leadership Community (ELC)
SaaS Interviews with CEOs, Startups, Founders
Nathan Latka